Filana Therapeutics Inc.
FLNA | NASDAQ
$0.57
-$0.05 (-8.36%)
Nov 2, 2026, 12:54 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 |
|---|---|---|---|---|---|---|
Net Income | -8.6M | -12.54M | -10.81M | -23.4M | -27.6M | -27.94M |
Depreciation & Amortization | 300K | 367K | 131K | 220K | 260K | 259K |
Stock-Based Compensation | n/a | n/a | 4.4M | n/a | 5.74M | 5.61M |
Other Working Capital | 331K | 1.18M | -2.91M | 6.08M | 4.92M | 4.09M |
Other Non-Cash Items | 4.02M | 5.37M | n/a | 5.23M | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 433K | -2.95M | 53K | 6.62M | -39.67M | 3.78M |
Operating Cash Flow | -3.86M | -9.75M | -6.22M | -11.34M | -61.27M | -18.3M |
Capital Expenditures | -21K | -501K | -80K | n/a | -57K | -17K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -21K | -501K | -80K | n/a | -57K | -17K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -16K | n/a | n/a | n/a | 918K | n/a |
Financial Cash Flow | -16K | -329K | n/a | 90K | 918K | n/a |
Net Cash Flow | -3.89M | -10.58M | -6.3M | -11.25M | -60.4M | -18.31M |
Free Cash Flow | -3.88M | -10.25M | -6.3M | -11.34M | -61.32M | -18.31M |
Adj. Free Cash Flow | -3.88M | -10.25M | -10.7M | -11.34M | -67.07M | -23.92M |
Maintenance CapEx | -21K | -367K | -80K | n/a | -57K | -17K |
Growth CapEx | n/a | -134K | n/a | n/a | n/a | n/a |
Owner Earnings | -3.88M | -10.12M | -6.3M | -11.34M | -61.32M | -18.31M |
Add to Watchlist
Select watchlists to add or remove FLNA